Table 1.

Patient characteristics

Table depicts the data of the investigated patients: age at transplantation, histology, chemotherapy induction protocol, disease status at transplant, type of conditioning regime, number of CD34-positive stem cells contained in the graft/kg body weight, day of engraftment after transplant and current disease status. Seven patients received two consecutive transplants. Out of 17 patients, 8 are currently alive; of these 4 patients are in CR, 4 are alive with disease; these patients are shaded in gray. 9 patients died of progressive disease. There was no transplant related mortality

CPM cyclophosphamid, CBCDA carboplatin, L-PAM melphalan, TTP thiotepa, VP-16 Etoposid, autoHSCT autologous stem cell transplantation, CR complete remission, PR partial response, VGPR very good partial response, SD stable disease, PD progressive disease, DOD dead of disease, ith intrathekal, engraftment first of three consecutive days with absolute neutrophile count of >500/μl